rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-12-17
|
pubmed:abstractText |
Information about the cost-effectiveness of aripiprazole relative to other atypical antipsychotics in the treatment of patients with schizophrenia is limited. This information is needed to better inform drug formulary managers and population-based health care decision makers. The objective of this study was to compare the cost-effectiveness of olanzapine to aripiprazole in the treatment of schizophrenia from the perspective of public payers in the United States.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1473-4877
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-22
|
pubmed:meshHeading |
pubmed-meshheading:21110749-Adolescent,
pubmed-meshheading:21110749-Adult,
pubmed-meshheading:21110749-Antipsychotic Agents,
pubmed-meshheading:21110749-Benzodiazepines,
pubmed-meshheading:21110749-Cost-Benefit Analysis,
pubmed-meshheading:21110749-Double-Blind Method,
pubmed-meshheading:21110749-Female,
pubmed-meshheading:21110749-Humans,
pubmed-meshheading:21110749-Male,
pubmed-meshheading:21110749-Middle Aged,
pubmed-meshheading:21110749-Multicenter Studies as Topic,
pubmed-meshheading:21110749-Piperazines,
pubmed-meshheading:21110749-Quinolones,
pubmed-meshheading:21110749-Randomized Controlled Trials as Topic,
pubmed-meshheading:21110749-Retrospective Studies,
pubmed-meshheading:21110749-Schizophrenia,
pubmed-meshheading:21110749-Treatment Outcome,
pubmed-meshheading:21110749-United States,
pubmed-meshheading:21110749-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia.
|
pubmed:affiliation |
Eli Lilly and Company, Lilly Corporate Center, DC 4133, Indianapolis, IN 46285, USA. haya@lilly.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|